# Application of BMSCs-coated PLGA/type I collagen composite mesh in intraperitoneal onlay mesh repair using a rat ventral incisional hernia model

**Authors:** Mingliang He, Yi Pan, Jiayi Li, Yaqin Qi, Kangbei Zhu, Fangjie Zhang

PMC · DOI: 10.3389/fbioe.2025.1663573 · 2025-10-31

## TL;DR

This study develops a new hernia repair mesh combining PLGA, collagen, and stem cells, which reduces inflammation and promotes tissue regeneration in rats.

## Contribution

A novel bioactive composite mesh using BMSCs, PLGA, and collagen is introduced for improved hernia repair with anti-adhesive and regenerative properties.

## Key findings

- The composite mesh reduced inflammatory cell infiltration by 73.3% compared to commercial meshes.
- BMSCs modulated TGF-β1/Smad3 signaling to mitigate fibrosis and enhance neovascularization.
- The mesh degraded at a rate matching tissue regeneration and showed minimal adhesions in histological analysis.

## Abstract

This study aimed to address the limitations of synthetic meshes in incisional hernia repair by developing a bioactive composite mesh combining poly(lactic-co-glycolic acid) (PLGA), type I collagen, and bone marrow mesenchymal stem cells (BMSCs).

The PLGA scaffolds, fabricated via freeze-drying, were modified with collagen to enhance biocompatibility and loaded with BMSCs to promote tissue regeneration. In vitro and in vivo evaluations in a rat ventral hernia model assessed biomechanical properties, anti-adhesion efficacy, and tissue integration.

The PLGA-Collagen I-BMSCs mesh exhibited superior anti-adhesion performance, reduced inflammatory cell infiltration by 73.3%, and enhanced neovascularization compared to commercial meshes (Sepramesh™ and Parietex™). BMSCs modulated TGF-β1/Smad3 signaling to mitigate fibrosis, while collagen alignment improved mechanical recovery. The composite mesh degraded at a rate matching tissue regeneration, with 10% PLGA maintaining structural integrity for 20 weeks. Histological analysis revealed organized collagen deposition and minimal adhesions (Nair grade 0–1 in 100% of cases).

These findings highlight the potential of the PLGA-Collagen I-BMSCs composite as an innovative intraperitoneal onlay mesh (IPOM) solution, offering mechanical stability, anti-adhesive properties, and regenerative bioactivity. This strategy shifts hernia repair from passive support to active tissue regeneration, providing a foundation for next-generation hernia repair materials.

## Linked entities

- **Proteins:** TGFB1 (transforming growth factor beta 1), SMAD3 (SMAD family member 3)
- **Chemicals:** PLGA (PubChem CID 36797)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Smad3 (SMAD family member 3) [NCBI Gene 25631] {aka Madh3, Smad 3, mad3}
- **Diseases:** fibrosis (MESH:D005355), ventral hernia (MESH:D006555), incisional hernia (MESH:D000069290), hernia (MESH:D006547), inflammatory (MESH:D007249)
- **Chemicals:** PLGA (MESH:D000077182)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12615440/full.md

---
Source: https://tomesphere.com/paper/PMC12615440